CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Juno Therapeutics, Inc. v. Kite Pharma, Inc.

1:16-cv-01243

Overview

Case Number 1:16-cv-01243
Filing Date 2016-12-19
Status Terminated
Termination Date 2017-06-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Kite Pharma, Inc. Operating Company

Represented By

7 Attorneys Listed

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Jay P. Lefkowitz

Email: lefkowitz@kirkland.com

Mira Mulvaney

Email: mira.mulvaney@kirkland.com

Nicole Kathleen Pedi

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7844
Fax: +1 (302) 498-7701

Richards, Layton & Finger, PA, One Rodney Square

Patricia A. Carson

Email: patricia.carson@kirkland.com

Mark C. McLennan

Email: mark.mclennan@kirkland.com

Leora Ben-Ami

Email: leora.benami@kirkland.com

Plaintiff

Sloan Kettering Institute for Cancer Research Operating Company

Represented By

1 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Memorial Sloan Kettering Cancer Center Operating Company

Represented By

1 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Juno Therapeutics, Inc. Operating Company

Represented By

5 Attorneys Listed

Alan J. Heinrich

Email: aheinrich@irell.com

Morgan Chu

Email: mchu@irell.com

Andrei Iancu

Email: aiancu@irell.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Elizabeth C. Tuan

Email: etuan@irell.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 1 U.S. Courts: 1
USPTO PTAB Trial 2015-08-13
IPR2015-01719

Kite Pharma, Inc. v. Sloan Kettering Institute for Cancer Research et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2017-10-18
2:17-cv-07639

Juno Therapeutics, Inc. v. Kite Pharma, Inc.

Asserted Patent
Status: CACD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7446190
Nucleic acids encoding chimeric T cell receptors
Filed: 2003-05-28
Issued: 2008-11-04
Expired (Term Ended) +458d PTA
Expires: 2024-08-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+458 days) / Cellect Scrutiny — Over 458 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

13

Dispositive

11

Granted

1

Denied

0

Pending / Review

10

Motions by Category

Procedural / Extension Motion 2 Motion to Dismiss 11

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
MEMORANDUM OPINION regarding Motion to Dismiss (D.I. 8 ). Signed by Judge Richard G. Andrews on 6/13/2017. (nms)
Entry #22 • 2017-06-13 Document →
Motion to Dismiss Granted
ORDER Granting Motion to Dismiss (D.I. 8 ). Signed by Judge Richard G. Andrews on 6/13/2017. (nms) (Entered: 06/13/2017)
Entry #23 • 2017-06-13 Document →
Motion to Dismiss Pending / Under Review
REQUEST for Oral Argument by Kite Pharma, Inc. re 8 MOTION to Dismiss. (Pedi, Nicole) (Entered: 04/11/2017)
Entry #21 • 2017-04-11 Document →
Motion to Dismiss Pending / Under Review
REPLY BRIEF re 8 MOTION to Dismiss, filed by Kite Pharma, Inc.. (Farnan, Kelly) Modified on 4/7/2017 (nms). (Entered: 04/06/2017)
Entry #19 • 2017-04-06 Document →
Motion to Dismiss Pending / Under Review
ANSWERING BRIEF in Opposition re 8 MOTION to Dismiss filed by Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Can...
Entry #16 • 2017-03-23 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME to file answering brief to motion to dismiss and reply brief in support of motion to March 23, 2017 and April 6, 2017, respectively -...
Entry #13 • 2017-02-24 Document →

Docket Entries

(52 total)
Pleading / Complaint

COMPLAINT FOR DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed against Kite Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2049496.) - filed by Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1-20, # 2 Civil Cover Sheet)(rwc) (Entered: 12/19/2016)

Entry #1 • 2016-12-19
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 12/19/2016)

Entry #2 • 2016-12-19
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,446,190 B2. (rwc) (Entered: 12/19/2016)

Entry #3 • 2016-12-19
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (rwc) (Entered: 12/19/2016)

Entry #4 • 2016-12-19
1
Pleading / Complaint

SUMMONS Returned Executed by Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Kite Pharma, Inc. served on 12/19/2016, answer due 1/9/2017. (Blumenfeld, Jack) (Entered: 12/19/2016)

Entry #5 • 2016-12-19
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc